Literature DB >> 9422962

Cost-effectiveness of coronary interventions.

D J Cohen1, C A Sukin.   

Abstract

Mesh:

Year:  1997        PMID: 9422962      PMCID: PMC484818          DOI: 10.1136/hrt.78.suppl_2.7

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  18 in total

Review 1.  Cost and health implications of cholesterol lowering.

Authors:  L Goldman; D J Gordon; B M Rifkind; S B Hulley; A S Detsky; D W Goodman; B Kinosian; M C Weinstein
Journal:  Circulation       Date:  1992-05       Impact factor: 29.690

2.  Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.

Authors:  H M Krumholz; R C Pasternak; M C Weinstein; G C Friesinger; P M Ridker; A N Tosteson; L Goldman
Journal:  N Engl J Med       Date:  1992-07-02       Impact factor: 91.245

3.  Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction.

Authors:  L Goldman; S T Sia; E F Cook; J D Rutherford; M C Weinstein
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

4.  Foundations of cost-effectiveness analysis for health and medical practices.

Authors:  M C Weinstein; W B Stason
Journal:  N Engl J Med       Date:  1977-03-31       Impact factor: 91.245

5.  Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989.

Authors:  J B Wong; F A Sonnenberg; D N Salem; S G Pauker
Journal:  Ann Intern Med       Date:  1990-12-01       Impact factor: 25.391

6.  Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery.

Authors:  D J Cohen; J A Breall; K K Ho; R M Weintraub; R E Kuntz; M C Weinstein; D S Baim
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

7.  In-hospital costs associated with new percutaneous coronary devices.

Authors:  R J Dick; J J Popma; D W Muller; K A Burek; E J Topol
Journal:  Am J Cardiol       Date:  1991-10-01       Impact factor: 2.778

8.  A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group.

Authors:  E J Topol; F Leya; C A Pinkerton; P L Whitlow; B Hofling; C A Simonton; R R Masden; P W Serruys; M B Leon; D O Williams
Journal:  N Engl J Med       Date:  1993-07-22       Impact factor: 91.245

9.  A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators.

Authors:  A F Parisi; E D Folland; P Hartigan
Journal:  N Engl J Med       Date:  1992-01-02       Impact factor: 91.245

10.  Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model.

Authors:  D J Cohen; J A Breall; K K Ho; R E Kuntz; L Goldman; D S Baim; M C Weinstein
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

View more
  1 in total

1.  Is a US analysis of cost-effectiveness in interventional cardiology relevant to a centrally funded health care system?

Authors:  D C Cumberland
Journal:  Heart       Date:  1997-10       Impact factor: 5.994

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.